Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Vollmer Louis J. — IBERE PHARMACEUTICALS insider: 1 transactions · InsiderLens

Home / Insiders / Vollmer Louis J.

Vollmer Louis J.

Director at IBERE PHARMACEUTICALS · on record since Feb 25, 2021

Insider trading activity of Vollmer Louis J.

Transactions on record: 1; since Mar 2, 2021

Open-market buys: 1; $100K

Open-market sells: 0

Companies traded: 1; last filing Mar 2, 2021

Figures computed from official regulatory filings — methodology.

Companies where Vollmer Louis J. has traded

IBERE PHARMACEUTICALS1 tx · $100K · Mar 2, 2021

Track record of Vollmer Louis J.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Vollmer Louis J.

Co-insiders of Vollmer Louis J.

Gray Lisa M.IBERE PHARMACEUTICALS
IMASOGIE OSAGIE OIBERE PHARMACEUTICALS
Johnson Calvin B.IBERE PHARMACEUTICALS
Jones Elaine VIBERE PHARMACEUTICALS
Kerekes ZoltanIBERE PHARMACEUTICALS
PIPV Capital LLCIBERE PHARMACEUTICALS
UKWU HENRIETTAIBERE PHARMACEUTICALS

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
IBERE PHARMACEUTICALS	Mar 2, 2021	Buy	10,000	10.00 USD	$100K	SEC